Objective To evaluate the clinical impact of fluorodeoxyglucose (FDG)-PET/computed
tomography (CT) scan on restaging breast cancer patients with rising tumor markers and …

Breast cancer is the most frequent cancer diagnosed in women worldwide. Accurate
baseline staging is necessary to plan optimal breast cancer management. Early detection …

Breast cancer represents the most frequent malignant disease in women and the second
leading cause of cancer death in western countries. Current available treatment includes …

Purpose This study examines the use of [18F] fluorodeoxyglucose positron emission
tomography (FDG-PET) for the evaluation of the therapeutic response for patients treated …

Background Despite the increasing use of positron emission tomography/computed
tomography (PET/CT) in the management of patients with breast cancer, its role is yet to be …

Abstract Purpose To compare [18 F]-fluorodeoxyglucose (FDG) and [18 F]-sodium fluoride
(NaF) positron emission tomography/computed tomography (PET/CT) with whole-body …

Assessing therapy response of breast cancer bone metastases is challenging. In
retrospective studies, serial 18F-FDG PET was predictive of time to skeletal-related events …

Background Breast cancer is the most frequent cancer in women and remains the second
leading cause of death in Western countries. It represents a heterogeneous group of …

In the last decades, in addition to conventional imaging techniques and magnetic resonance
imaging (MRI), 18F-fluorodeoxyglucose positron emission tomography/computed …

Purpose We retrospectively reviewed FDG-PET/CT images in patients with breast cancer to
determine whether PET/CT improved the level of diagnostic confidence as compared with …